P0852 : Clinical characteristics and outcomes of chronic hepatitis C (CHC) patients treated with newer direct-acting antiviral (DAA)-based regimens from a large US payer perspective

A S L D A b st ra ct s clinics. Conclusions: Individuals present to the health care system at various point of care sites. However, despite institutional education programs and widespread national publicity even at an academic outpatient setting the majority of baby boomers eligible for screening have not undergone HCV screening. This is even lower in the ED, a site of health care disproportionately accessed by patients at increased risk for HCV. Although all point of care aspects in our institution could improve screening, targeted intervention in the ER has both the highest chance for improvement as well as access to the largest group of at risk individuals. To actualize any expected public health benefits of rapidly evolving HCV therapy, identifying systems issues that that may explain the low screening rates, especially at sites highly accessed may improve HCV screening and linkage to care. Interventions that improve screening rates in our outpatient clinics could be applied to the ED.